Nothing that I saw in this result, nor read in the accompanying commentary and presentation was anything that would have been overly novel or revealing to the market.
The only problem I see is that, at the current EV of ~$1.5bn, that stock is currently already pricing in a level of EBIT of circa ~$150m, which is a good 60% uplift from the current run-rate, and which is around 75% to 80% of what I consider to be the cyclical maximum $200m EBIT earnings capacity of the business.
So, the stock is running more on macro-momentum right now, than on any clear and obvious under-valuation, I think.
Nothing that I saw in this result, nor read in the accompanying...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MND (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.42 |
Change
-0.010(0.08%) |
Mkt cap ! $1.222B | |||
| Open | High | Low | Value | Volume |
| $12.45 | $12.50 | $12.30 | $2.678M | 215.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 552 | $12.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.43 | 360 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MND (ASX) Chart |
